Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Prepaid Assets (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Prepaid Assets data on record, last reported at $13.4 million in Q4 2025.

  • For Q4 2025, Prepaid Assets fell 26.33% year-over-year to $13.4 million; the TTM value through Dec 2025 reached $13.4 million, down 26.33%, while the annual FY2025 figure was $13.4 million, 26.33% down from the prior year.
  • Prepaid Assets reached $13.4 million in Q4 2025 per MRVI's latest filing, down from $14.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $25.8 million in Q4 2022 and bottomed at $8.9 million in Q1 2021.
  • Average Prepaid Assets over 5 years is $18.2 million, with a median of $17.8 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: skyrocketed 78.31% in 2022, then plummeted 34.13% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $19.7 million in 2021, then soared by 30.97% to $25.8 million in 2022, then dropped by 26.55% to $18.9 million in 2023, then decreased by 4.24% to $18.1 million in 2024, then decreased by 26.33% to $13.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $13.4 million in Q4 2025, $14.4 million in Q3 2025, and $15.3 million in Q2 2025.